About Agios (AGIO)
Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more
- USD39.59
- USD39.79
- USD38.70
- USD62.58
- 14.40%
- 37M
- 699.04k
- 635.03k
- 2.3B
- 23.42
- -14.50%
Stock News
1 hour ago
S&P 500 stumbles after hitting intraday high — the downside of a narrow rally
MarketWatch
1 hour ago
Amazon turns to rival SpaceX to launch next batch of Kuiper internet satellites
CNBC
2 hours ago
GM expands production of gas-powered SUV, trucks in Michigan
CNBC
3 hours ago
Trump's new trade deal promises billions to the U.S. — plus, reasons behind the mixed market
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
